Pulmonx Corp
Offers minimally invasive valves to treat severe emphysema/COPD and improve breathing.
LUNG | NDAQ
Overview
Corporate Details
- ISIN(s):
- US7458481014
- LEI:
- Country:
- United States of America
- Address:
- 700 CHESAPEAKE DRIVE, 94063 REDWOOD CITY
- Website:
- https://pulmonx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Pulmonx Corporation is a commercial-stage medical technology company specializing in minimally invasive treatments for severe lung diseases. The company's principal product is the Zephyr® Endobronchial Valve, a breakthrough device for patients with severe emphysema/COPD. The Zephyr Valve is an implantable device delivered via a non-surgical bronchoscopic procedure, designed to reduce hyperinflation and improve breathing. It is a clinically proven treatment demonstrated to enhance lung function, exercise capacity, and quality of life for qualifying patients, positioning Pulmonx as a global leader in interventional pulmonology solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Pulmonx Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pulmonx Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pulmonx Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
